Results 241 to 250 of about 1,171,277 (292)

ICSH Guidance on Bone Marrow Examination and Reporting

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Examination of the bone marrow (BM) remains fundamental to the diagnosis, classification, prognostication, and monitoring of hematolymphoid and other disorders affecting blood cell production. Since publication of the International Council for Standardization in Haematology (ICSH) guideline in 2008, advances in diagnostic technologies, disease
Wendy N. Erber, Alexandar Tzankov, Olga Pozdnyakova, Hiromichi Matsushita, Gina Zini, Leonie Saft, on behalf of the International Council for Standardization in Haematology   +6 more
wiley   +1 more source

Maternal Bleeding Outcomes in Pregnant Women With Immune Thrombocytopenia (ITP): A National Database Study. [PDF]

Cureus
Araji M, Al Saidi I, Khamis Z, Mustafa A, Ajami Z, Ezzedine D, Araji G, Bershadskiy A.   +7 more
europepmc   +1 more source

Unsupervised Global CBC/RUO/CPD Phenotyping Identifies Haematological Clusters Enriched for Thrombocytopenia Severity and Mechanisms

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction Thrombocytopenia has heterogeneous mechanisms, including peripheral destruction, consumption, and reduced marrow production. This study developed an unsupervised global complete blood count/research‐use‐only/cell population data (CBC/RUO/CPD) phenotyping model and evaluated post hoc whether thrombocytopenia severity and clinically
Mohammad A. Altememi, Emmanuel J. Favaloro, Md Zahidul Islam, Sara Ng, Danny Hsu, Abishek B. Santhakumar   +5 more
wiley   +1 more source

Association between vaccine-induced immune thrombocytopenia and thrombosis and human leucocyte antigen loci: Yes, no or maybe? [PDF]

Br J Haematol
Petito E, Bury L, Heck LA, Di Paola J, Gresele P.   +4 more
europepmc   +1 more source

Maternal and Neonatal Outcomes of Immune Thrombocytopenia in Pregnancy: A Five-Year Single-Center Cross-Sectional Study. [PDF]

Health Sci Rep
Elkorashi S, Magboul H, Al-Mashdali AF, Alnajjar M, AlMallahi N, Abdalla E, Soliman DS, Aldali S, Elsheikh M, Cherif H, Mohamed SF.   +10 more
europepmc   +1 more source

MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopenia. [PDF]

Br J Haematol
Liu Z, Rebetz J, Garabet L, Ghanima W, Xu P, Wadenvik H, Provan D, Kapur R, Semple JW.   +8 more
europepmc   +1 more source

Safety and efficacy of daratumumab in immune thrombocytopenia. [PDF]

Blood Adv
Tsykunova G, Holme PA, Tran HTT, Frederiksen H, Tjønnfjord E, Munthe LA, Drivet E, Kared H, Sørvoll IH, Ahlen MT, Mahévas M, Michel M, Bussel J, Kuter DJ, Anderson Tvedt TH, Ghanima W.   +15 more
europepmc   +1 more source

Tuberculosis and immune thrombocytopenia

Haematologica, 2002
M Madkaikar, K Ghosh, F Jijina, M Gupta, M Rajpurkar, D Mohanty   +5 more
doaj  

Novel use of telitacicept in primary immune thrombocytopenia: a case report. [PDF]

BMC Pediatr
Wang Y, Wang J, Hu B, Zhou Y, Rao Y, Lu M, Xu X.   +6 more
europepmc   +1 more source

Short- and long-term outcome of neonates with thrombocytopenia from maternal immune thrombocytopenia. [PDF]

Br J Haematol
Sorin B, Azzouguen B, Loustau V, Boutin E, Henique H, Graveleau J, Souchaud-Debouverie O, Pascal L, Gilardin L, Costedoat-Chalumeau N, Reynaud Q, Pan-Petesch B, Cheze S, Terriou L, Comont T, Sauvetre G, Royer B, Mahévas M, Michel M, Canoui-Poitrine F, Godeau B, Guillet S.   +21 more
europepmc   +1 more source